167 related articles for article (PubMed ID: 14638550)
21. Apoptosis in serum-deprived vascular smooth muscle cells: evidence for cell volume-independent mechanism.
Orlov SN; Pchejetski D; Taurin S; Thorin-Trescases N; Maximov GV; Pshezhetsky AV; Rubin AB; Hamet P
Apoptosis; 2004 Jan; 9(1):55-66. PubMed ID: 14739599
[TBL] [Abstract][Full Text] [Related]
22. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
[TBL] [Abstract][Full Text] [Related]
23. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
24. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis.
Meng N; Zhao J; Zhao B; Cheng Y; Wang W; Zhang Y; Zhang S; Miao J
J Cell Biochem; 2008 Aug; 104(6):2123-30. PubMed ID: 18393353
[TBL] [Abstract][Full Text] [Related]
25. Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na
Klimanova EA; Tverskoi AM; Koltsova SV; Sidorenko SV; Lopina OD; Tremblay J; Hamet P; Kapilevich LV; Orlov SN
Sci Rep; 2017 Mar; 7():45403. PubMed ID: 28345607
[TBL] [Abstract][Full Text] [Related]
26. Na/K-ATPase endocytosis couples pumping and leaking activities in renal epithelial cells: a hypothesis.
Liu J
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):97-104. PubMed ID: 17535743
[TBL] [Abstract][Full Text] [Related]
27. Effect of m-calpain in PKCalpha-mediated proliferation of pulmonary artery smooth muscle cells by low dose of ouabain.
Shaikh S; Sarkar J; Pramanik A; Karmakar K; Chakraborti S
Indian J Biochem Biophys; 2013 Oct; 50(5):419-27. PubMed ID: 24772963
[TBL] [Abstract][Full Text] [Related]
28. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
[TBL] [Abstract][Full Text] [Related]
29. Vascular effects of altered sodium, potassium pump activity.
Mulvany MJ
Scand J Clin Lab Invest Suppl; 1986; 180():40-8. PubMed ID: 3012761
[No Abstract] [Full Text] [Related]
30. Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells.
Odenlund M; Holmqvist B; Baldetorp B; Hellstrand P; Nilsson BO
Amino Acids; 2009 Feb; 36(2):273-82. PubMed ID: 18368465
[TBL] [Abstract][Full Text] [Related]
31. Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells.
Qin XP; Ye F; Hu CP; Liao DF; Deng HW; Li YJ
Eur J Pharmacol; 2004 Mar; 488(1-3):45-9. PubMed ID: 15044034
[TBL] [Abstract][Full Text] [Related]
32. Tormentic acid reduces vascular smooth muscle cell proliferation and survival.
Fogo AS; Antonioli E; Calixto JB; Campos AH
Eur J Pharmacol; 2009 Aug; 615(1-3):50-4. PubMed ID: 19464287
[TBL] [Abstract][Full Text] [Related]
33. Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism.
Kotova O; Al-Khalili L; Talia S; Hooke C; Fedorova OV; Bagrov AY; Chibalin AV
J Biol Chem; 2006 Jul; 281(29):20085-94. PubMed ID: 16714287
[TBL] [Abstract][Full Text] [Related]
34. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with digibind. Stoichiometry and its implications.
Krep HH; Graves SW; Price DA; Lazarus M; Ensign A; Soszynski PA; Hollenberg NK
Am J Hypertens; 1996 Jan; 9(1):39-46. PubMed ID: 8834705
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
[TBL] [Abstract][Full Text] [Related]
36. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
Fedorova OV; Dorofeeva NA; Lopatin DA; Lakatta EG; Bagrov AY
Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of vascular smooth muscle cells treated with ouabain.
Pshezhetsky AV
Methods Mol Biol; 2007; 357():253-69. PubMed ID: 17172693
[TBL] [Abstract][Full Text] [Related]
38. Sodium pumps: ouabain, ion transport, and signaling in hypertension.
Blaustein MP; Hamlyn JM; Pallone TL
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F438; author reply F439. PubMed ID: 17616574
[No Abstract] [Full Text] [Related]
39. Analysis of exercise-induced Na+-K+ exchange in rat skeletal muscle in vivo.
Murphy KT; Nielsen OB; Clausen T
Exp Physiol; 2008 Dec; 93(12):1249-62. PubMed ID: 18586859
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
